Replicel
Replicel Terminates License With Shiseido: Update (12/21/21) Two months after Replicel announced that it was entering arbitration proceedings with Shiseido, the company has announced today that it has terminated its license agreement with Shiseido. The license agreement between Replicel and Shiseido dates back to 2013 when Shiseido paid an upfront fee to gain the rights…
Read More
Yesterday, Replicel released a May 2019 Update which mentioned a new study using its dermal injector device to treat hair loss. The end of the press release states: “Over the next 18 months you should expect to see: new clinical data from a study completed showing the value of the dermal injector in treating hair…
Read MoreReplicel has shared a newsletter today, March 5, 2019, addressing several facets of the company’s progress and product development. The big question for many people lately has been an update on RCH-01/Shiseido, this topic is briefly addressed in the newsletter. Replicel states that “With the clinical study of RCH-01 now successfully completed in Japan, RepliCel…
Read More
After I shared an update about a potential announcement time frame for Shiseido a few weeks ago, I read a few queries from readers who wondered if a Shiseido market release would be available to everyone in the world. Today, I received more positive news from a credible source to help clear things up. Once again,…
Read More
Follicle Thought has received a brief update to share regarding the progress of the highly anticipated company Shiseido. On July 4th I sent a tweet to Replicel CEO Lee Buckler asking him when he thought we would hear an announcement from Shiseido pertaining to their trial of RCH-01. His response is shown below. As you…
Read More
As one of the top two hair growth treatments projected to reach the market in 2018, Replicel’s RCH-01 has a lot of people’s attention these days. When it was announced that the global cosmetic company Shiseido would trial Replicel’s hair growth technology in Japan, there was also talk from Shiseido that the treatment could reach…
Read MoreA Happy New Year to all of you from Follicle Thought. I’ve always enjoyed doing the year ahead preview posts and this one is no exception. A new year does bring us new opportunities and should be a reason for renewed hope. This is also the first year since I’ve started Follicle Thought that a…
Read More
Hello Everyone, It is good to be back for another Weekly Thoughts. This edition is headlined by an anti-aging technology from The Netherlands that has shown interesting regenerative effects on mice. I even got some exclusive info on the potential of this technology to be applied to hair growth to share with you. Also, we…
Read MoreReplicel’s hair growth therapy, RCH-01, has officially received approval by Japanese regulatory authorities to be used in a clinical trial that is now launching. We did hear some rumblings recently that Shiseido was putting the final touches on it’s clinical trial to take place at the Tokyo Medical University Hospital and Toho University Ohasi Medical…
Read MoreHello Everybody, Welcome to another edition of Weekly Thoughts. This weeks’s round-up includes new tidbits from Angela Christiano, Brian Urlacher’s hair transplant, Shiseido’s plethora of reseachers, and an Ultimate Guide update. Dr. Christiano Sheds Light on JAK Inhibitors Angela Christiano recently did an audio interview about her research on JAK inhibitors for hair growth. The…
Read More